Pharmaceutical substances based on affinity reagents of immunoglobulin or no-immunoglobulin origin for cancer diagnostics, prognostics and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection and in-vivo imaging, mainly for cancer cells in-vitro or in-vivo, all for medical or diagnostic purposes; medical substances and preparations based on affinity reagents of immunoglobulin or no-immunoglobulin origin for cancer diagnostics, prognostics and treatment; biological preparations for pharmaceutical use for cancer diagnostics, prognostics and treatment.
Scientific and medical research and development in the field of biochemistry/biotechnology, diagnostics and pharmaceutical/medical substances and preparations.
REGISTERED
on 31 Aug 2015
TRIPLEAPOLYCLONALSDESIGN
ATLAS ANTIBODIES AB
1642639 · 09 Sep 2013
005
Class 005
Pharmaceutical Products
Pharmaceutical substances based on affinity reagents of immunoglobulin or no-immunoglobulin origin for cancer diagnostics, prognostics and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection and in-vivo imaging, mainly for cancer cells in-vitro or in-vivo, all for medical or diagnostic purposes; medical substances and preparations based on affinity reagents of immunoglobulin or no-immunoglobulin origin for cancer diagnostics, prognostics and treatment; biological preparations for pharmaceutical use for cancer diagnostics, prognostics and treatment.
Scientific and medical research and development in the field of biochemistry/biotechnology, diagnostics and pharmaceutical/medical substances and preparations.
Pharmaceutical substances based on affinity reagents of immunoglobulin...
